Markets:

Overview

News

Currencies

International

Treasuries

Biodexa Pharmaceuticals plc - American Depositary Shares (NQ:BDRX)

1.320 -0.160 (-10.81%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biodexa Pharmaceuticals plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 19, 2025

Via Benzinga

With Fast Track Designation in Hand, a Successful Protocol Discussion with FDA, and CROs in Place, Biodexa is on Track to Initiate its Funded Phase 3 Trial in FAP Next Quarter

March 19, 2025

Via ACCESS Newswire

Gapping stocks in Tuesday's session ↗

March 11, 2025

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

March 11, 2025

As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

Biodexa's MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer

October 17, 2024

Via ACCESSWIRE

What's going on in today's after hours session ↗

March 10, 2025

After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Via Chartmill

Top movers in Monday's pre-market session ↗

March 10, 2025

The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

Unusual volume stocks in Wednesday's session ↗

February 12, 2025

On Wednesday, there are stocks with unusual volume. Let's take a look.

Via Chartmill

Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status

February 12, 2025

Via ACCESS Newswire

How Is The Market Feeling About Biodexa Pharmaceuticals? ↗

July 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 11, 2025

Via Benzinga

Crude Oil Rises Sharply; Manhattan Associates Shares Slide ↗

February 10, 2025

Via Benzinga

Biodexa Stock Surges On FDA's Fast-Track Tag For Treatment Of Cancer-Causing Condition: Retail Confidence Peaks ↗

February 10, 2025

The drug, a proprietary encapsulated form of rapamycin, is being developed for familial adenomatous polyposis (FAP), a condition that, if left untreated, universally leads to colorectal cancer.

Via Stocktwits

Nasdaq Surges 1%; ON Semiconductor Shares Plunge Following Earnings Miss ↗

February 10, 2025

Via Benzinga

Dow Gains 100 Points; McDonald's Shares Rise After Q4 Results ↗

February 10, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 21, 2024

Via Benzinga

Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic

November 21, 2024

Via ACCESSWIRE

BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm

October 28, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm

October 20, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 17, 2024

Via Benzinga

Why Is Brain Cancer-Focused Biodexa Pharmaceuticals Stock Trading Lower On Thursday? ↗

October 17, 2024

Biodexa Pharmaceuticals reports updates from the MAGIC-1 study on MTX110 for recurrent glioblastoma. MTX110 has also demonstrated potential in treating diffuse midline glioma, a rare brain cancer, with...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 16, 2024

Via Benzinga

Biodexa Pharmaceuticals Stock Is Soaring After The Close: What's Driving Shares Higher? ↗

October 15, 2024

Biodexa Pharmaceuticals shares are soaring in Tuesday's after-hours session after the company announced it was granted an extension to demonstrate compliance with Nasdaq listing requirements.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 02, 2024

Via Benzinga

Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 12, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 12, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.